Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
22
2022
The Weeds Thicken: Making Sense of the Ninth Circuit’s Decision Finding Delta-8 Legal Under Federal Law Bradley Arant Boult Cummings LLP
Jun
22
2022
A Truly Piscatory Exemption Allen Matkins Leck Gamble Mallory & Natsis LLP
Jun
22
2022
FDA Publishes Guidance on Oversight of Food Covered by SRAs Keller and Heckman LLP
Jun
21
2022
ACA Transparency in Coverage Disclosure Deadline for Health Plans Is Around the Corner. Are You (and Your Provider) Ready? Jones Walker LLP
Jun
21
2022
Cannabis Banking: Will the SAFE Banking Act Finally Pass? Bradley Arant Boult Cummings LLP
Jun
21
2022
Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next K&L Gates
Jun
21
2022
FDA Provides Updates on Closer to Zero Plan Keller and Heckman LLP
Jun
21
2022
Canada Publishes Draft Framework for the Risk Assessment of Manufactured Nanomaterials under CEPA Bergeson & Campbell, P.C.
Jun
21
2022
EPA Proposes New Rules Governing Section 401 Water Quality Certification K&L Gates
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jun
20
2022
Supreme Court Saves Hospitals from $1.6B Cut to 340B Program Sheppard, Mullin, Richter & Hampton LLP
Jun
17
2022
Pre-Employment Drug Testing Not Compensable Under California Law Holds Ninth Circuit Jackson Lewis P.C.
Jun
17
2022
“A Full Plate”: FTC’s Open Meeting on PBMs, AI, Privacy and Online Harms Proskauer Rose LLP
Jun
17
2022
Drug Development in the Metaverse ArentFox Schiff LLP
Jun
17
2022
HELP Committee Approves Bill to Address Infant Formula Shortage Keller and Heckman LLP
Jun
16
2022
FDA Responds to Severe Weather Incidents Keller and Heckman LLP
Jun
16
2022
Employer Need Not Reimburse Travel Expenses for Drug Test Proskauer Rose LLP
Jun
16
2022
SCOTUS Sides with 340B Hospitals and Denies CMS’s Attempt to Cut Reimbursement for 340B Drugs Polsinelli PC
Jun
16
2022
EPA’s New Drinking Water Health Advisories for PFAS Chemicals ArentFox Schiff LLP
Jun
16
2022
Wisconsin Legislative Committee will Allow PFAS Standards to Take Effect von Briesen & Roper, s.c.
Jun
16
2022
Recent Federal Developments: June 2022 Bergeson & Campbell, P.C.
Jun
15
2022
Supreme Court Decides in Favor of 340B Hospitals Regarding Medicare Reimbursement Methodology Robinson & Cole LLP
Jun
15
2022
What the Court’s Treatment of Roe and a Workers’ Compensation Case Reveal about President Biden’s Approach to Cannabis Bradley Arant Boult Cummings LLP
Jun
15
2022
Beyond Meat Sued Over Protein Content Claims Keller and Heckman LLP
Jun
14
2022
EUON Announces Update to NanoData Bergeson & Campbell, P.C.
Jun
14
2022
Excusing False Positive Drug Test Caused by CBD Use May Be a Reasonable Accommodation, Says U.S. District Court in Louisiana Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
14
2022
Class Action Lawsuits Follow in Wake of JIF Recall Keller and Heckman LLP
Jun
14
2022
Washington, D.C. Bill Would Limit Employers’ Ability to Discipline Based on Marijuana Testing Proskauer Rose LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins